FDA to revoke Avastin for breast cancer
December 16, 2010 at 13:07 PM EST
The FDA makes good on its plans to begin rescinding market approval for the Genentech-developed drug Avastin as a treatment of advanced breast cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.